Horizons in Healthcare Research
Total Page:16
File Type:pdf, Size:1020Kb
30 30 Horizons in Healthcare Research Friday 1st March 2019, Sydney University Program 1.00 – 1.30 Registration and light lunch 1.30 – 1.35 Welcome and opening Julie McCrossin/ A patient’s perspective Prof Tony Keech Dr Teresa Chairs: Prof Alicia Jenkins & Julie McCrossin Anderson AM 1.35 – 1.45 Cardio-metabolic: 30 years in 10 minutes Prof Philip Aylward Dr Teresa Anderson is the Chief Executive of Sydney Local Health District, one of the 1.45 - 1.55 Cancer trials: 30 years in 10 minutes Prof John Simes leading public health services in Australia. She has more than 35 years of experience 1.55 – 2.05 Neonatal trials: 30 years in 10 minutes Prof William Tarnow-Mordi as a clinician and health service executive. She has a well-established reputation 2.05 – 2.15 Return on investment of clinical trials A/Prof Rachael Morton for implementing strategies to foster innovation and best practice, supporting Global reach of Australian trials Prof Anna Nowak 2.15 – 2.30 Speaker collaboration and building partnerships. 2.30 – 2.45 The digital future Prof Jonathan Morris Teresa is an internationally recognised Biographies Speech Pathologist and is passionate 2.45 – 3.00 Panel discussion Julie McCrossin about developing programs and services to support and improve the health and 3.00 – 3.30 Afternoon tea wellbeing of all people in the community. In 2018 she was appointed a Member of Chairs: Prof Lisa Askie & Julie McCrossin the Order of Australia (AM). 3.30 – 3.45 RCTs in a self-improving health care system Prof John Zalcberg Dr Anderson is a member of seven Medical Research, Health and PHN boards and is 3.45 – 4.00 The future of clinical trial funding Prof Anne Kelso an active member of the Sydney Health Partners Governing Council and Executive 4.00 – 4.20 Data sharing in clinical trials Dr Jeff Drazen, MD Management Group, one of the first four centres in Australia designated by the 4.20 – 4.35 Panel discussion Julie McCrossin NHMRC as an Advanced Health Research Translation Centre. Chairs: Dr Teresa Anderson & Julie McCrossin 4.35 – 4.45 Prioritising research - A consumer’s perspective Melinda Cruz 4.45 – 5.00 Molecular & genomic driven trials – Precision medicine A/Prof Mustafa Khasraw 5.00 – 5.15 Attracting industry trials to Australia Dr Glenn Begley 5.15 – 5.30 Panel discussion Julie McCrossin 5.30 Wrap up and close Prof Tony Keech 5.30 – 7.30 Cocktail Reception, The Refectory Room, Holme Building Professor Professor Dr C. Glenn Melinda Lisa Askie Philip Aylward Begley Cruz Professor Askie leads a team at the CTC, Professor Aylward is Professor of Medicine Dr C. Glenn Begley is the inaugural CEO Melinda Cruz is the mother of three babies University of Sydney, which manages the at Flinders University and the Director of of BioCurate, a joint initiative of Monash born prematurely and is the award-winning Australian New Zealand Clinical Trials Strategic Relationships within the Southern and Melbourne Universities, created to Founder of Miracle Babies Foundation, Registry, undertakes Health Technology Adelaide Local Health Network. He is a provide commercial focus in the early Australia’s largest and leading neonatal Assessments for the Australian Federal Member of the Innovation Centre within phases of drug development. consumer group. Melinda was appointed as Government, hosts two Cochrane SAHMRI Heart Health and leads the an Honorary Research Associate at the CTC, Collaboration entities (Breast Cancer development of Education Programmes. Glenn served as Chief Scientific Officer at and was the first parent to be an Associate Review Group, Prospective Meta-analysis Akriveia Therapeutics, California (2016– Investigator on a CTC neonatal trial, LIFT. Methods Group) and has an extensive Philip is a Cardiologist with over two 2017) and TetraLogic Pharmaceuticals, test evaluation research program. decades of involvement in clinical trials. Pennsylvania (2012–2016). From Melinda is a trusted consumer expert He has been a National Co-ordinator and 2002–2012, he was Vice-President and to medical professionals seeking to Lisa’s clinical background is in perinatal member of a number of international Global Head of Haematology/Oncology improve treatments and understanding medicine and she has worked in steering and executive committees in Research at Amgen, responsible for of premature and sick babies and the healthcare systems in Asia, Australia, cardiology, particularly in acute coronary building, directing and integrating Amgen’s impact a birth has on the family unit. In UK and USA. She has Masters and syndromes, lipid management, atrial five research sites. 2014, Melinda joined the PSANZ Consumer Doctoral qualifications in epidemiology fibrillation and heart failure. Advisory Panel and accepted a position from Sydney Medical School, is a Senior Before Amgen, Glenn had over 20 years on the PSANZ Clinical Trials executive Principal Research Fellow at the University Philip was Co-chair and author of the initial of clinical experience in medical oncology committee. In 2016, she was asked to of Sydney and has held an NHMRC Australian Guidelines for the Management and haematology. His personal research join the NHMRC Clinical Trials Ready Postgraduate Scholarship, a Sidney of Acute Coronary Syndromes 2006 and focused on regulation of haematopoietic Development Committee and contributed Sax Postdoctoral Fellowship, a Career was a Member of the 2017 Acute Coronary cells and translational clinical trials. to the dissemination of the results of Development Fellowship and currently, Syndrome Guidelines Writing Committee of His early studies first described human BOOST II and APTS trials. In 2015, she a Translating Research Into Practice the National Heart Foundation and Cardiac G-CSF, and in later clinical studies, first joined the Australian Red Cross Blood (TRIP) Fellowship. Society of Australia & New Zealand. demonstrated that G-CSF-mobilised blood Service Milk Bank Advisory Committee. stem cells hastened haematopoietic recovery. This finding revolutionised Under Melinda’s leadership, Miracle the clinical approach to bone marrow Babies Foundation has established a major transplantation. impact and reach, with almost 60,000 likes on Facebook and an active and engaged Glenn’s honours include being elected as audience on Twitter, Instagram and the first Foreign Fellow to the American LinkedIn. Melinda was recently invited to Society of Clinical Investigation in 2000, to become a regular contributor to THRIVE the Association of American Physicians in Global, an international portal for health 2008, to the Research ‘Hall of Fame’ at his and wellbeing, in which she has published alma mater, the Royal Melbourne Hospital, five articles to date. in 2014, and to the Australian Academy of Health and Medical Sciences in 2016. She is currently working on publishing her first book. Dr Jeff Professor Professor Professor Drazen Alicia Jenkins Tony Keech Anne Kelso Dr Jeff Drazen joined the New England Alicia Jenkins is a Professor of Diabetes Professor Tony Keech is Senior Principal Professor Anne Kelso AO is the Chief Journal of Medicine (NEJM) as Editor- and Vascular Medicine at the CTC. She Research Fellow and Deputy Director of the Executive Officer of the NHMRC. Following in-Chief in July of 2000. In 2012, he was has collaborated with the CTC since 2000 CTC. He co-leads the research team at the her PhD at the University of Melbourne, appointed Editor-in-Chief of NEJM Group, and she and her team moved to the CTC CTC and for the last ten years has chaired Anne undertook research in the field of which also publishes NEJM Journal Watch, in 2012 / 13. She trained at the University the CTC’s Research Committee. immunology, first in Switzerland and then NEJM Knowledge+, NEJM Catalyst, NEJM of Melbourne (Australia), in Ireland, the at the Walter and Eliza Hall Institute of Resident 360, and NEJM Yi Xue Qian Yan. UK, and the US. She is an endocrinologist Tony is Professor of Medicine, Cardiology Medical Research in Melbourne and the with clinical and research interests in and Epidemiology at the University of Queensland Institute of Medical Research A specialist in pulmonology, Jeff maintains diabetes and its complications, including Sydney, an internationally renowned in Brisbane. an active research program. He has the use of technology in diabetes care, researcher in the field of cardiovascular published more than 300 articles on topics as well as insulin pumps, glucose sensors clinical trials, and Chair and Principal From 2000 until 2006, Anne was also such as lung physiology and the mechanisms and telehealth. With over 25 years of Investigator of the FIELD diabetes study. Director/CEO of the Cooperative Research involved in asthma. Throughout his research experience Alicia leads clinical His research has influenced health Centre for Vaccine Technology. She then distinguished career, he has served many and basic science research exploring outcomes, particularly in treatments of returned to Melbourne as Director of the academic and hospital appointments and diabetes and its complications, clinical, acute myocardial infarction, cardiovascular WHO Collaborating Centre for Reference received numerous honours. biochemical and molecular biomarkers, disease prevention of chronic heart and Research on Influenza from 2007 and trials, including the FIELD, T4DM, disease, and diabetes and its vascular until she took up her role with NHMRC Jeff is the Distinguished Parker B. Francis DCCT/EDIC, REMOVAL, FAME-1 trials and complications. He is recognised in April 2015. Professor of Medicine at Harvard Medical insulin pump studies. Alicia has over 350 internationally for collaborative research School, Professor of Physiology at the publications and mentors a wide range of into coronary risk factors, treatments for Anne is a current member of several Harvard School of Public Health, and a clinician researchers. She holds a NHMRC acute coronary syndromes, prediction government and international committees, senior physician at Brigham and Women’s Practitioner Fellowship, she has served on of vascular disease, and treatment and including the Australian Medical Research Hospital.